Estonija - estonski - Ravimiamet

vetoquinol biowet sp. z o.o. - tiamuliin - suukaudse lahuse graanulid - 450mg 1g 1000g 1tk

Estonija - estonski - Ravimiamet

vetoquinol biowet sp. z o.o. - enrofloksatsiin - süstelahus - 50mg 1ml 100ml 1tk

Estonija - estonski - Ravimiamet

vetoquinol biowet sp. z o.o. - enrofloksatsiin - suukaudne lahus - 100mg 1ml 50ml 1tk

Estonija - estonski - Ravimiamet

vetoquinol biowet sp. z o.o. - tiamuliin - süstelahus - 162,2mg 1ml 100ml 1tk

Estonija - estonski - Ravimiamet

vetoquinol biowet sp. z o.o. - ketamiin - süstelahus - 100mg 1ml 50ml 1tk; 100mg 1ml 10ml 1tk

Estonija - estonski - Ravimiamet

andermatt biovet gmbh - oksaalhape - taru ravimpulber - 1,43g 200g 1tk; 1,43g 2g 50tk; 1,43g 75g 1tk

Europska Unija - estonski - EMA (European Medicines Agency)

zoetis belgium sa - meloksikaam - oxicams - koerad - põletiku ja valu leevendamine koertel nii ägedate kui ka krooniliste lihas-skeleti kahjustuste korral.

Europska Unija - estonski - EMA (European Medicines Agency)

a. menarini industrie farmaceutiche riunite s.r.l. - delafloxacin meglumine - Ühenduse omandatud infektsioonid - antibacterials süsteemseks kasutamiseks, - quofenix is indicated for the treatment of the following infections in adults:acute bacterial skin and skin structure infections (absssi),community-acquired pneumonia (cap), when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections (see sections 4. 4 ja 5. tuleks arvesse võtta ametlikke juhiseid sobiva kasutada antibakteriaalseid aineid.

Europska Unija - estonski - EMA (European Medicines Agency)

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastilised ained - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.

Europska Unija - estonski - EMA (European Medicines Agency)

virbac s.a. - puhastatud p45 felv-ümbrise antigeen - inaktiveeritud viiruse vaktsiinide, kasside leukeemia viiruse, immunoloogilised ravimid jaoks felidae, - kassid - kahe nädala vanuste kasside aktiivne immuniseerimine kasside leukeemia vastu püsiva viiraemia ja selle haiguse kliiniliste tunnuste ennetamiseks.